nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A2—Cisplatin—esophageal cancer	0.034	1	CbGbCtD
Disopyramide—Fesoterodine—ABCB1—esophageal cancer	0.00734	0.372	CrCbGaD
Disopyramide—Levomethadyl Acetate—CYP19A1—esophageal cancer	0.00684	0.346	CrCbGaD
Disopyramide—Haemoglobin decreased—Capecitabine—esophageal cancer	0.00601	0.0232	CcSEcCtD
Disopyramide—Torsade de pointes—Capecitabine—esophageal cancer	0.0059	0.0227	CcSEcCtD
Disopyramide—Pain—Carboplatin—esophageal cancer	0.00584	0.0225	CcSEcCtD
Disopyramide—Ventricular fibrillation—Capecitabine—esophageal cancer	0.0054	0.0208	CcSEcCtD
Disopyramide—Body temperature increased—Carboplatin—esophageal cancer	0.00539	0.0208	CcSEcCtD
Disopyramide—Tingling sensation—Capecitabine—esophageal cancer	0.00514	0.0198	CcSEcCtD
Disopyramide—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00449	0.0173	CcSEcCtD
Disopyramide—Cyanosis—Methotrexate—esophageal cancer	0.00435	0.0168	CcSEcCtD
Disopyramide—Methadone—CYP19A1—esophageal cancer	0.00401	0.203	CrCbGaD
Disopyramide—Dry eye—Capecitabine—esophageal cancer	0.00382	0.0147	CcSEcCtD
Disopyramide—Blood creatinine increased—Cisplatin—esophageal cancer	0.00381	0.0147	CcSEcCtD
Disopyramide—Hypokalaemia—Cisplatin—esophageal cancer	0.00371	0.0143	CcSEcCtD
Disopyramide—Apnoea—Methotrexate—esophageal cancer	0.00363	0.014	CcSEcCtD
Disopyramide—Sweating increased—Cisplatin—esophageal cancer	0.00343	0.0132	CcSEcCtD
Disopyramide—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00325	0.0125	CcSEcCtD
Disopyramide—Cardiac failure—Capecitabine—esophageal cancer	0.00308	0.0119	CcSEcCtD
Disopyramide—Diplopia—Capecitabine—esophageal cancer	0.003	0.0116	CcSEcCtD
Disopyramide—Bradycardia—Cisplatin—esophageal cancer	0.00287	0.0111	CcSEcCtD
Disopyramide—Cardiac arrest—Capecitabine—esophageal cancer	0.00285	0.011	CcSEcCtD
Disopyramide—Urinary retention—Capecitabine—esophageal cancer	0.00285	0.011	CcSEcCtD
Disopyramide—Coma—Methotrexate—esophageal cancer	0.00281	0.0108	CcSEcCtD
Disopyramide—Blood creatinine increased—Capecitabine—esophageal cancer	0.00281	0.0108	CcSEcCtD
Disopyramide—Gynaecomastia—Methotrexate—esophageal cancer	0.00275	0.0106	CcSEcCtD
Disopyramide—Abdominal pain upper—Capecitabine—esophageal cancer	0.00274	0.0106	CcSEcCtD
Disopyramide—Hypokalaemia—Capecitabine—esophageal cancer	0.00273	0.0105	CcSEcCtD
Disopyramide—Muscular weakness—Capecitabine—esophageal cancer	0.00265	0.0102	CcSEcCtD
Disopyramide—Abdominal distension—Capecitabine—esophageal cancer	0.00261	0.0101	CcSEcCtD
Disopyramide—Sweating increased—Capecitabine—esophageal cancer	0.00253	0.00974	CcSEcCtD
Disopyramide—Arrhythmia—Cisplatin—esophageal cancer	0.00252	0.0097	CcSEcCtD
Disopyramide—Dysuria—Capecitabine—esophageal cancer	0.00243	0.00935	CcSEcCtD
Disopyramide—Neutropenia—Capecitabine—esophageal cancer	0.00243	0.00935	CcSEcCtD
Disopyramide—Flatulence—Cisplatin—esophageal cancer	0.00242	0.00931	CcSEcCtD
Disopyramide—Weight increased—Capecitabine—esophageal cancer	0.00236	0.0091	CcSEcCtD
Disopyramide—Vision blurred—Cisplatin—esophageal cancer	0.00231	0.00891	CcSEcCtD
Disopyramide—Depression—Capecitabine—esophageal cancer	0.00231	0.00889	CcSEcCtD
Disopyramide—Ill-defined disorder—Cisplatin—esophageal cancer	0.00228	0.00877	CcSEcCtD
Disopyramide—Malaise—Cisplatin—esophageal cancer	0.00221	0.00852	CcSEcCtD
Disopyramide—Agranulocytosis—Capecitabine—esophageal cancer	0.00216	0.00832	CcSEcCtD
Disopyramide—Bradycardia—Capecitabine—esophageal cancer	0.00211	0.00815	CcSEcCtD
Disopyramide—Hepatitis—Capecitabine—esophageal cancer	0.00208	0.008	CcSEcCtD
Disopyramide—Hypoaesthesia—Capecitabine—esophageal cancer	0.00207	0.00796	CcSEcCtD
Disopyramide—Discomfort—Cisplatin—esophageal cancer	0.00206	0.00795	CcSEcCtD
Disopyramide—Oedema—Cisplatin—esophageal cancer	0.002	0.00771	CcSEcCtD
Disopyramide—Thrombocytopenia—Cisplatin—esophageal cancer	0.00196	0.00755	CcSEcCtD
Disopyramide—Skin disorder—Cisplatin—esophageal cancer	0.00194	0.00749	CcSEcCtD
Disopyramide—Hyperhidrosis—Cisplatin—esophageal cancer	0.00193	0.00746	CcSEcCtD
Disopyramide—Anorexia—Cisplatin—esophageal cancer	0.00191	0.00735	CcSEcCtD
Disopyramide—Hypotension—Cisplatin—esophageal cancer	0.00187	0.00721	CcSEcCtD
Disopyramide—Arrhythmia—Capecitabine—esophageal cancer	0.00186	0.00715	CcSEcCtD
Disopyramide—Dysuria—Methotrexate—esophageal cancer	0.00181	0.00696	CcSEcCtD
Disopyramide—Neutropenia—Methotrexate—esophageal cancer	0.00181	0.00696	CcSEcCtD
Disopyramide—Paraesthesia—Cisplatin—esophageal cancer	0.0018	0.00692	CcSEcCtD
Disopyramide—Dyspnoea—Cisplatin—esophageal cancer	0.00178	0.00688	CcSEcCtD
Disopyramide—Flatulence—Capecitabine—esophageal cancer	0.00178	0.00686	CcSEcCtD
Disopyramide—Erectile dysfunction—Methotrexate—esophageal cancer	0.00178	0.00685	CcSEcCtD
Disopyramide—Dysgeusia—Capecitabine—esophageal cancer	0.00177	0.00682	CcSEcCtD
Disopyramide—Decreased appetite—Cisplatin—esophageal cancer	0.00174	0.0067	CcSEcCtD
Disopyramide—Drowsiness—Methotrexate—esophageal cancer	0.00172	0.00664	CcSEcCtD
Disopyramide—Depression—Methotrexate—esophageal cancer	0.00172	0.00662	CcSEcCtD
Disopyramide—Pain—Cisplatin—esophageal cancer	0.00171	0.00659	CcSEcCtD
Disopyramide—Vision blurred—Capecitabine—esophageal cancer	0.0017	0.00656	CcSEcCtD
Disopyramide—Ill-defined disorder—Capecitabine—esophageal cancer	0.00168	0.00646	CcSEcCtD
Disopyramide—Feeling abnormal—Cisplatin—esophageal cancer	0.00165	0.00635	CcSEcCtD
Disopyramide—Malaise—Capecitabine—esophageal cancer	0.00163	0.00628	CcSEcCtD
Disopyramide—Vertigo—Capecitabine—esophageal cancer	0.00162	0.00626	CcSEcCtD
Disopyramide—Syncope—Capecitabine—esophageal cancer	0.00162	0.00625	CcSEcCtD
Disopyramide—Agranulocytosis—Methotrexate—esophageal cancer	0.00161	0.00619	CcSEcCtD
Disopyramide—Loss of consciousness—Capecitabine—esophageal cancer	0.00159	0.00612	CcSEcCtD
Disopyramide—Body temperature increased—Cisplatin—esophageal cancer	0.00158	0.0061	CcSEcCtD
Disopyramide—Methadone—ABCB1—esophageal cancer	0.00157	0.0793	CrCbGaD
Disopyramide—Hepatitis—Methotrexate—esophageal cancer	0.00155	0.00596	CcSEcCtD
Disopyramide—Chest pain—Capecitabine—esophageal cancer	0.00154	0.00593	CcSEcCtD
Disopyramide—Discomfort—Capecitabine—esophageal cancer	0.00152	0.00586	CcSEcCtD
Disopyramide—Dry mouth—Capecitabine—esophageal cancer	0.00151	0.0058	CcSEcCtD
Disopyramide—Confusional state—Capecitabine—esophageal cancer	0.00149	0.00573	CcSEcCtD
Disopyramide—Oedema—Capecitabine—esophageal cancer	0.00148	0.00568	CcSEcCtD
Disopyramide—Shock—Capecitabine—esophageal cancer	0.00145	0.00559	CcSEcCtD
Disopyramide—Thrombocytopenia—Capecitabine—esophageal cancer	0.00144	0.00557	CcSEcCtD
Disopyramide—Asthenia—Cisplatin—esophageal cancer	0.00144	0.00553	CcSEcCtD
Disopyramide—Skin disorder—Capecitabine—esophageal cancer	0.00143	0.00552	CcSEcCtD
Disopyramide—Hyperhidrosis—Capecitabine—esophageal cancer	0.00143	0.0055	CcSEcCtD
Disopyramide—Anorexia—Capecitabine—esophageal cancer	0.00141	0.00542	CcSEcCtD
Disopyramide—Hypotension—Capecitabine—esophageal cancer	0.00138	0.00531	CcSEcCtD
Disopyramide—Diarrhoea—Cisplatin—esophageal cancer	0.00137	0.00528	CcSEcCtD
Disopyramide—Insomnia—Capecitabine—esophageal cancer	0.00133	0.00514	CcSEcCtD
Disopyramide—Paraesthesia—Capecitabine—esophageal cancer	0.00132	0.0051	CcSEcCtD
Disopyramide—Dysgeusia—Methotrexate—esophageal cancer	0.00132	0.00508	CcSEcCtD
Disopyramide—Dyspnoea—Capecitabine—esophageal cancer	0.00132	0.00507	CcSEcCtD
Disopyramide—Dyspepsia—Capecitabine—esophageal cancer	0.0013	0.005	CcSEcCtD
Disopyramide—Decreased appetite—Capecitabine—esophageal cancer	0.00128	0.00494	CcSEcCtD
Disopyramide—Vomiting—Cisplatin—esophageal cancer	0.00127	0.0049	CcSEcCtD
Disopyramide—Fatigue—Capecitabine—esophageal cancer	0.00127	0.0049	CcSEcCtD
Disopyramide—Vision blurred—Methotrexate—esophageal cancer	0.00127	0.00489	CcSEcCtD
Disopyramide—Rash—Cisplatin—esophageal cancer	0.00126	0.00486	CcSEcCtD
Disopyramide—Constipation—Capecitabine—esophageal cancer	0.00126	0.00486	CcSEcCtD
Disopyramide—Pain—Capecitabine—esophageal cancer	0.00126	0.00486	CcSEcCtD
Disopyramide—Dermatitis—Cisplatin—esophageal cancer	0.00126	0.00486	CcSEcCtD
Disopyramide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00125	0.00481	CcSEcCtD
Disopyramide—Feeling abnormal—Capecitabine—esophageal cancer	0.00122	0.00468	CcSEcCtD
Disopyramide—Malaise—Methotrexate—esophageal cancer	0.00121	0.00468	CcSEcCtD
Disopyramide—Vertigo—Methotrexate—esophageal cancer	0.00121	0.00466	CcSEcCtD
Disopyramide—Nausea—Cisplatin—esophageal cancer	0.00119	0.00458	CcSEcCtD
Disopyramide—Urticaria—Capecitabine—esophageal cancer	0.00117	0.00452	CcSEcCtD
Disopyramide—Body temperature increased—Capecitabine—esophageal cancer	0.00117	0.00449	CcSEcCtD
Disopyramide—Chest pain—Methotrexate—esophageal cancer	0.00115	0.00441	CcSEcCtD
Disopyramide—Discomfort—Methotrexate—esophageal cancer	0.00113	0.00436	CcSEcCtD
Disopyramide—Confusional state—Methotrexate—esophageal cancer	0.00111	0.00427	CcSEcCtD
Disopyramide—Thrombocytopenia—Methotrexate—esophageal cancer	0.00108	0.00414	CcSEcCtD
Disopyramide—Skin disorder—Methotrexate—esophageal cancer	0.00107	0.00411	CcSEcCtD
Disopyramide—Hyperhidrosis—Methotrexate—esophageal cancer	0.00106	0.00409	CcSEcCtD
Disopyramide—Asthenia—Capecitabine—esophageal cancer	0.00106	0.00408	CcSEcCtD
Disopyramide—Anorexia—Methotrexate—esophageal cancer	0.00105	0.00403	CcSEcCtD
Disopyramide—Pruritus—Capecitabine—esophageal cancer	0.00104	0.00402	CcSEcCtD
Disopyramide—Hypotension—Methotrexate—esophageal cancer	0.00103	0.00395	CcSEcCtD
Disopyramide—Diarrhoea—Capecitabine—esophageal cancer	0.00101	0.00389	CcSEcCtD
Disopyramide—Insomnia—Methotrexate—esophageal cancer	0.000993	0.00383	CcSEcCtD
Disopyramide—Paraesthesia—Methotrexate—esophageal cancer	0.000986	0.0038	CcSEcCtD
Disopyramide—Dyspnoea—Methotrexate—esophageal cancer	0.000979	0.00377	CcSEcCtD
Disopyramide—Somnolence—Methotrexate—esophageal cancer	0.000976	0.00376	CcSEcCtD
Disopyramide—Dizziness—Capecitabine—esophageal cancer	0.000976	0.00376	CcSEcCtD
Disopyramide—Dyspepsia—Methotrexate—esophageal cancer	0.000967	0.00373	CcSEcCtD
Disopyramide—Decreased appetite—Methotrexate—esophageal cancer	0.000955	0.00368	CcSEcCtD
Disopyramide—Fatigue—Methotrexate—esophageal cancer	0.000947	0.00365	CcSEcCtD
Disopyramide—Pain—Methotrexate—esophageal cancer	0.000939	0.00362	CcSEcCtD
Disopyramide—Vomiting—Capecitabine—esophageal cancer	0.000938	0.00361	CcSEcCtD
Disopyramide—Rash—Capecitabine—esophageal cancer	0.00093	0.00358	CcSEcCtD
Disopyramide—Dermatitis—Capecitabine—esophageal cancer	0.000929	0.00358	CcSEcCtD
Disopyramide—Headache—Capecitabine—esophageal cancer	0.000924	0.00356	CcSEcCtD
Disopyramide—Feeling abnormal—Methotrexate—esophageal cancer	0.000905	0.00349	CcSEcCtD
Disopyramide—Nausea—Capecitabine—esophageal cancer	0.000876	0.00338	CcSEcCtD
Disopyramide—Urticaria—Methotrexate—esophageal cancer	0.000873	0.00336	CcSEcCtD
Disopyramide—Body temperature increased—Methotrexate—esophageal cancer	0.000868	0.00335	CcSEcCtD
Disopyramide—Asthenia—Methotrexate—esophageal cancer	0.000788	0.00304	CcSEcCtD
Disopyramide—Pruritus—Methotrexate—esophageal cancer	0.000777	0.00299	CcSEcCtD
Disopyramide—Diarrhoea—Methotrexate—esophageal cancer	0.000751	0.0029	CcSEcCtD
Disopyramide—Dizziness—Methotrexate—esophageal cancer	0.000726	0.0028	CcSEcCtD
Disopyramide—Vomiting—Methotrexate—esophageal cancer	0.000698	0.00269	CcSEcCtD
Disopyramide—Rash—Methotrexate—esophageal cancer	0.000693	0.00267	CcSEcCtD
Disopyramide—Dermatitis—Methotrexate—esophageal cancer	0.000692	0.00267	CcSEcCtD
Disopyramide—Headache—Methotrexate—esophageal cancer	0.000688	0.00265	CcSEcCtD
Disopyramide—Nausea—Methotrexate—esophageal cancer	0.000652	0.00251	CcSEcCtD
Disopyramide—SLC22A1—Metabolism—ALOX15—esophageal cancer	0.000385	0.00056	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FKBP1A—esophageal cancer	0.000384	0.000559	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FKBP1A—esophageal cancer	0.000383	0.000557	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000382	0.000556	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000381	0.000555	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—EP300—esophageal cancer	0.000379	0.000552	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FKBP1A—esophageal cancer	0.000379	0.000552	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000378	0.00055	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALDOB—esophageal cancer	0.000377	0.00055	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000377	0.000549	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—ANXA1—esophageal cancer	0.000376	0.000548	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—WIF1—esophageal cancer	0.000375	0.000546	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TYMP—esophageal cancer	0.000375	0.000546	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—WIF1—esophageal cancer	0.000374	0.000545	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—ANXA1—esophageal cancer	0.000373	0.000543	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—WIF1—esophageal cancer	0.00037	0.000539	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL2—esophageal cancer	0.000369	0.000537	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL2—esophageal cancer	0.000368	0.000536	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—SST—esophageal cancer	0.000367	0.000535	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TPI1—esophageal cancer	0.000367	0.000534	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTO1—esophageal cancer	0.000367	0.000534	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—SST—esophageal cancer	0.000366	0.000533	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP26A1—esophageal cancer	0.000365	0.000531	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	0.000364	0.00053	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GAPDH—esophageal cancer	0.000363	0.000529	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—SST—esophageal cancer	0.000363	0.000528	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CRABP1—esophageal cancer	0.00036	0.000524	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.000358	0.000521	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—GHRL—esophageal cancer	0.000357	0.00052	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALOX15—esophageal cancer	0.000355	0.000517	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	0.000353	0.000515	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALDOB—esophageal cancer	0.000352	0.000512	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000346	0.000504	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CSNK1A1—esophageal cancer	0.000345	0.000503	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000343	0.000499	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GNG7—esophageal cancer	0.000343	0.000499	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—ANXA1—esophageal cancer	0.000342	0.000498	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000342	0.000498	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TPI1—esophageal cancer	0.000339	0.000494	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTO1—esophageal cancer	0.000339	0.000494	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GAPDH—esophageal cancer	0.000339	0.000493	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	0.000339	0.000493	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CRABP1—esophageal cancer	0.000336	0.000489	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—SST—esophageal cancer	0.000334	0.000486	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—SST—esophageal cancer	0.000333	0.000484	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—SST—esophageal cancer	0.000329	0.00048	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000328	0.000478	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000327	0.000477	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	0.000325	0.000474	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALDOB—esophageal cancer	0.000325	0.000473	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—GHRL—esophageal cancer	0.000324	0.000472	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PFN1—esophageal cancer	0.000324	0.000472	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—EGFR—esophageal cancer	0.000323	0.00047	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PFN1—esophageal cancer	0.000323	0.00047	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	0.000321	0.000467	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALDH2—esophageal cancer	0.000321	0.000467	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PFN1—esophageal cancer	0.00032	0.000466	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GNG7—esophageal cancer	0.000319	0.000465	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000319	0.000464	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000318	0.000463	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GAPDH—esophageal cancer	0.000313	0.000456	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CRABP1—esophageal cancer	0.00031	0.000452	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTT1—esophageal cancer	0.000305	0.000445	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP2A6—esophageal cancer	0.000302	0.000439	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALDH2—esophageal cancer	0.000299	0.000436	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GNG7—esophageal cancer	0.000295	0.000429	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	0.000291	0.000424	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	0.000291	0.000424	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ELMO1—esophageal cancer	0.00029	0.000422	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	0.000287	0.000418	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS1—esophageal cancer	0.000286	0.000417	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ENO1—esophageal cancer	0.000286	0.000417	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000286	0.000416	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000285	0.000415	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTT1—esophageal cancer	0.000285	0.000414	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	0.000284	0.000414	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000284	0.000414	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	0.000283	0.000413	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PSME2—esophageal cancer	0.000282	0.000411	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PSME1—esophageal cancer	0.000282	0.000411	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP2A6—esophageal cancer	0.000281	0.00041	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	0.000281	0.000409	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALDH2—esophageal cancer	0.000276	0.000402	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ENO1—esophageal cancer	0.000267	0.000388	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS1—esophageal cancer	0.000267	0.000388	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000266	0.000388	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTT1—esophageal cancer	0.000263	0.000383	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PSME2—esophageal cancer	0.000263	0.000383	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PSME1—esophageal cancer	0.000263	0.000383	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000262	0.000382	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000262	0.000381	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	0.00026	0.000379	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP2A6—esophageal cancer	0.00026	0.000378	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	0.000259	0.000378	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000259	0.000377	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	0.000257	0.000374	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GNG7—esophageal cancer	0.000247	0.00036	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GNG7—esophageal cancer	0.000247	0.000359	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ENO1—esophageal cancer	0.000246	0.000359	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS1—esophageal cancer	0.000246	0.000359	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GNG7—esophageal cancer	0.000244	0.000356	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP1B1—esophageal cancer	0.000243	0.000354	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PSME1—esophageal cancer	0.000243	0.000353	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PSME2—esophageal cancer	0.000243	0.000353	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000242	0.000352	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000242	0.000352	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—XIAP—esophageal cancer	0.000232	0.000338	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—XIAP—esophageal cancer	0.000231	0.000337	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—XIAP—esophageal cancer	0.000229	0.000333	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP19A1—esophageal cancer	0.000229	0.000333	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP1B1—esophageal cancer	0.000227	0.00033	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.000219	0.000319	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	0.000219	0.000318	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000218	0.000317	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	0.000217	0.000316	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	0.000216	0.000315	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	0.000215	0.000313	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP19A1—esophageal cancer	0.000213	0.00031	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP1B1—esophageal cancer	0.000209	0.000305	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—HMOX1—esophageal cancer	0.000209	0.000304	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000206	0.000299	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CA1—esophageal cancer	0.000206	0.000299	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PSME2—esophageal cancer	0.000204	0.000296	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PSME1—esophageal cancer	0.000204	0.000296	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PSME2—esophageal cancer	0.000203	0.000296	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PSME1—esophageal cancer	0.000203	0.000296	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000203	0.000295	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	0.000202	0.000294	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PSME1—esophageal cancer	0.000201	0.000293	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PSME2—esophageal cancer	0.000201	0.000293	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ABCB1—esophageal cancer	0.0002	0.000292	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	0.0002	0.000291	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SST—esophageal cancer	0.000197	0.000287	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP19A1—esophageal cancer	0.000197	0.000287	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SST—esophageal cancer	0.000196	0.000286	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SST—esophageal cancer	0.000195	0.000283	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—HMOX1—esophageal cancer	0.000195	0.000283	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GHRL—esophageal cancer	0.000192	0.00028	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.000192	0.00028	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	0.000191	0.000279	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GHRL—esophageal cancer	0.000191	0.000279	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	0.00019	0.000276	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GHRL—esophageal cancer	0.00019	0.000276	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	0.000189	0.000275	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	0.000188	0.000274	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CA2—esophageal cancer	0.000188	0.000274	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ABCB1—esophageal cancer	0.000187	0.000272	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	0.000187	0.000272	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—HMOX1—esophageal cancer	0.00018	0.000262	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000175	0.000255	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000175	0.000255	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ABCB1—esophageal cancer	0.000172	0.000251	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	0.000172	0.000251	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	0.000172	0.00025	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	0.00017	0.000248	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000153	0.000223	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	0.000153	0.000223	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	0.000152	0.000222	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	0.000151	0.00022	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000147	0.000213	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	0.000145	0.000211	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	0.000144	0.00021	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	0.000143	0.000208	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000143	0.000208	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000139	0.000202	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CREBBP—esophageal cancer	0.000134	0.000195	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000133	0.000193	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000133	0.000193	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.000127	0.000185	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CREBBP—esophageal cancer	0.000125	0.000182	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GAPDH—esophageal cancer	0.000122	0.000178	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CRABP1—esophageal cancer	0.000121	0.000177	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NOS3—esophageal cancer	0.00012	0.000175	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	0.000118	0.000172	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	0.000118	0.000172	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	0.000117	0.00017	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GNG7—esophageal cancer	0.000115	0.000168	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CREBBP—esophageal cancer	0.000115	0.000168	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KDR—esophageal cancer	0.000113	0.000165	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KDR—esophageal cancer	0.000113	0.000164	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KDR—esophageal cancer	0.000112	0.000163	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NOS3—esophageal cancer	0.000112	0.000163	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—esophageal cancer	0.00011	0.00016	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDH2—esophageal cancer	0.000108	0.000157	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	0.000107	0.000155	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	0.000106	0.000155	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	0.000105	0.000153	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NOS3—esophageal cancer	0.000103	0.00015	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTT1—esophageal cancer	0.000103	0.00015	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—esophageal cancer	0.000102	0.000149	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	0.000102	0.000148	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	9.67e-05	0.000141	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	9.64e-05	0.00014	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS1—esophageal cancer	9.63e-05	0.00014	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ENO1—esophageal cancer	9.63e-05	0.00014	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	9.54e-05	0.000139	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	9.5e-05	0.000138	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PSME2—esophageal cancer	9.49e-05	0.000138	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PSME1—esophageal cancer	9.49e-05	0.000138	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	9.47e-05	0.000138	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—esophageal cancer	9.44e-05	0.000137	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	9.38e-05	0.000137	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—EP300—esophageal cancer	9.12e-05	0.000133	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	9.08e-05	0.000132	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	9.05e-05	0.000132	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	8.96e-05	0.000131	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOS3—esophageal cancer	8.66e-05	0.000126	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOS3—esophageal cancer	8.63e-05	0.000126	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOS3—esophageal cancer	8.55e-05	0.000124	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—EP300—esophageal cancer	8.5e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	8.25e-05	0.00012	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	8.22e-05	0.00012	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	8.19e-05	0.000119	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	8.14e-05	0.000119	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	8.1e-05	0.000118	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	8.07e-05	0.000118	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	7.99e-05	0.000116	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—EP300—esophageal cancer	7.85e-05	0.000114	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	7.7e-05	0.000112	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCND1—esophageal cancer	7.15e-05	0.000104	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCND1—esophageal cancer	7.13e-05	0.000104	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCND1—esophageal cancer	7.06e-05	0.000103	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.02e-05	0.000102	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	6.92e-05	0.000101	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	6.9e-05	0.0001	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	6.83e-05	9.95e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CA—esophageal cancer	6.74e-05	9.82e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCB1—esophageal cancer	6.74e-05	9.82e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EP300—esophageal cancer	6.58e-05	9.59e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EP300—esophageal cancer	6.56e-05	9.56e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EP300—esophageal cancer	6.5e-05	9.47e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CA—esophageal cancer	6.29e-05	9.15e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CA—esophageal cancer	5.81e-05	8.46e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—esophageal cancer	5.74e-05	8.36e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—esophageal cancer	5.72e-05	8.33e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—esophageal cancer	5.66e-05	8.25e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGFR—esophageal cancer	5.61e-05	8.17e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGFR—esophageal cancer	5.59e-05	8.15e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGFR—esophageal cancer	5.54e-05	8.07e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	4.87e-05	7.09e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	4.86e-05	7.07e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	4.81e-05	7e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—esophageal cancer	4.71e-05	6.86e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—esophageal cancer	4.7e-05	6.84e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—esophageal cancer	4.65e-05	6.77e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.51e-05	6.56e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NOS3—esophageal cancer	4.03e-05	5.88e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.69e-05	5.37e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—EP300—esophageal cancer	3.07e-05	4.47e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.27e-05	3.31e-05	CbGpPWpGaD
